Pre-clinical evaluation of a novel [¹⁸F]-labeled d-TCO amide derivative for bioorthogonal pretargeted imaging of cancer

Ruivo, E, Elvas, F, Vangestel, C et al. (6 more authors) (2019) Pre-clinical evaluation of a novel [¹⁸F]-labeled d-TCO amide derivative for bioorthogonal pretargeted imaging of cancer. In: Journal of Labelled Compounds and Radiopharmaceuticals. ISRS 2019, 26-31 May 2019, Beijing, China. John Wiley & Sons Inc. , S479-S480.

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2019 The Authors. Journal of Labelled Compounds and Radiopharmaceuticals © 2019 John Wiley & Sons, Ltd. This is the post-peer reviewed version of the following conference poster, Ruivo, E, Elvas, F, Vangestel, C et al. (6 more authors) (2019) Pre-clinical evaluation of a novel [¹⁸F]-labeled d-TCO amide derivative for bioorthogonal pretargeted imaging of cancer. In: Journal of Labelled Compounds and Radiopharmaceuticals. ISRS 2019, 26-31 May 2019, Beijing, China. John Wiley & Sons Inc. , S479-S480, which has been published in final form at https://doi.org/10.1002/jlcr.3725. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.
Dates:
  • Accepted: 1 April 2019
  • Published (online): 24 May 2019
  • Published: May 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Biological Sciences (Leeds) > School of Molecular and Cellular Biology (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 03 Jul 2019 11:15
Last Modified: 24 May 2020 00:38
Status: Published
Publisher: John Wiley & Sons Inc.
Identification Number: https://doi.org/10.1002/jlcr.3725
Related URLs:

Export

Statistics